Milnacipran for the treatment of fibromyalgia syndrome: a european multicenter, double-blind, placebo-controlled trial

被引：1
|
作者：
Branco, J. [1 ]
Bragee, G.
Zachrisson, O. [2 ]
Mikkelsen, K. [3 ]
De Teresa, L. [4 ]
Mainguy, Y. [5 ]
Galissie, M. [5 ]
Lugardon, S. [5 ]
Pezous, N.
机构：
[1] Lisboa Ocident EPE Hosp Egas Moniz, Serv Reumatol, Ctr Hosp, Lisbon, Portugal
[2] Gottfriesclin AB, Molndal, Sweden
[3] Revmatismesykehuset AS, Rheumatol, Lillehammer, Norway
[4] Clin Mediterranea Neurociencas, Dept Med Interna, Alicante, Spain
[5] Inst Rech Pierre Fabre, Labege, France
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2008年 / 18卷
关键词：
D O I：
10.1016/S0924-977X(08)70878-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S574 / S575
页数：2
相关论文
共 50 条
  • [1] A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia
    Vitton, O
    Gendreau, M
    Gendreau, J
    Kranzler, J
    Rao, SG
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2004, 19 : S27 - S35
  • [2] Milnacipran for the treatment of fibromyalgia syndrome: A randomized, double-blind, placebo-controlled trial
    Clauw, Daniel J.
    Palmer, Robert H.
    Thacker, Kim
    Gendreau, R. Michael
    Mease, Philip
    [J]. NEUROLOGY, 2008, 70 (11) : A162 - A162
  • [3] A European Multicenter Randomized Double-blind Placebo-controlled Monotherapy Clinical Trial of Milnacipran in Treatment of Fibromyalgia
    Branco, Jaime C.
    Zachrisson, Olof
    Perrot, Serge
    Mainguy, Yves
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (04) : 851 - 859
  • [4] The beneficial effect of milnacipran on Fibromyalgia syndrome is not related with antidepressant properties: A European multicenter, double-blind, placebo-controlled trial
    Branco, Jaime C.
    Bragee, Bjorn
    Zachrisson, Olof
    Mikkelsen, Knut
    De Teresa, Luis
    Mainguy, Yves
    Galissie, Martine
    Lugardon, Stephanie
    Pezous, Nicole
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S384 - S384
  • [5] Double-blind placebo controlled trial of milnacipran in the treatment of fibromyalgia
    Vitton, O
    Gendreau, M
    Kranzier, J
    Rao, S
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S93 - S93
  • [6] Effect of Milnacipran on Pain in Fibromyalgia: A European, Double-Blind, Randomized, Placebo-Controlled Trial
    Branco, Jaime C.
    Danneskiold-Samsoe, Bent
    Cherin, Patrick
    Cantagrel, N.
    Vitton, Olivier
    Bunouf, Pierre
    Mainguy, Yves
    [J]. ANNALS OF NEUROLOGY, 2009, 66 : S4 - S5
  • [7] Milnacipran efficacy in the treatment of fibromyalgia syndrome: A 15-week, randomized, double-blind, placebo-controlled trial
    Clauw, Daniel J.
    Palmer, Robert H.
    Thacker, Kim
    Gendreau, R. Michael
    Mease, Philip
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4231 - 4231
  • [8] Gabapentin in the treatment of fibromyalgia - A randomized, double-blind, placebo-controlled, multicenter trial
    Arnold, Lesley M.
    Goldenberg, Don L.
    Stanford, Sharon B.
    Lalonde, Justine K.
    Sandhu, H. S.
    Keck, Paul E., Jr.
    Welge, Jeffrey A.
    Bishop, Fred
    Stanford, Kevin E.
    Hess, Evelyn V.
    Hudson, James I.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (04): : 1336 - 1344
  • [9] Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Natelson, Benjamin H.
    Vu, Diana
    Mao, Xiangling
    Weiduschat, Nora
    Togo, Fumiharu
    Lange, Gudrun
    Blate, Michelle
    Kang, Guoxin
    Coplan, Jeremy D.
    Shungu, Dikoma C.
    [J]. JOURNAL OF PAIN, 2015, 16 (11): : 1211 - 1219
  • [10] Pregabalin for the treatment of fibromyalgia syndrome - Results of a randomized, double-blind, placebo-controlled trial
    Crofford, LJ
    Rowbotham, MC
    Mease, PJ
    Russell, IJ
    Dworkin, RH
    Corbin, AE
    Young, JP
    LaMoreaux, LK
    Martin, SA
    Sharma, U
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (04): : 1264 - 1273
12345